Suppression of TNF-alpha-induced IL-8 secretion from intestinal epithelial cells via secreted factors independent of NF-kappaB pathway inhibition

This target represents a strategy to reduce intestinal inflammation by suppressing the secretion of IL-8 from intestinal epithelial cells in response to TNF-alpha. The approach focuses on utilizing secreted factors that act through mechanisms independent of NF-kappaB pathway inhibition, offering a potential way to selectively modulate inflammatory responses in the gut without broadly suppressing the immune system. This might involve modulating pathways such as JNK/AP-1 or utilizing microRNAs such as miR-200b, or microbial metabolites.

Modulation of IL-8 secretion in intestinal epithelial cells stimulated by TNF-alpha via secreted factors that do not inhibit the NF-kappaB pathway. Mechanisms include modulation at the transcriptional or post-transcriptional level, interference with upstream signaling cascades, or effects mediated by microbial metabolites/host-derived peptides.